Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
New OHE Publications: An EQ-5D-5L Value Set for England
22 March 2016
Two newly published OHE Research Papers report the methods and findings of the ‘EQ-5D-5L value set for England’ study.
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
Health interventions can produce economic gains for patients and national economies. In practice, however, the health-wealth link is rarely considered.
New ISPOR Task Force Report on Multiple Criteria Decision Analysis
9 February 2016
Professor Nancy Devlin co-chaired the ISPOR task force on uses of MCDA in health care decision making. The first report from the task force has just…
From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers
19 January 2016
Paula Lorgelly, Deputy Director of OHE, reviews HTA decision making processes in three comparable countries, and considers the agency problem and possible solutions.
An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’
1 December 2016
This Research Paper explores decisions by the National Institute for Health and Care Excellence (NICE) that new technologies are to be recommended in line with clinical practice (RiLCP). The authors qualitatively assess documentation associated with RiLCP decisions to create a framework to describe common themes, and assess the level of patient access associated with each RiLCP decision.
Seminar at Glasgow Caledonian University: Local Health Care Expenditure Plans and Their Opportunity Costs
11 January 2016
OHE’s Sarah Karlsberg Schaffer presented at the Glasgow Health Economics Seminar Series the results of a paper on the value of the cost-effectiveness threshold in Scotland.
Uncertainty and Risk in HTA Decision Making
1 November 2016
The quality of decision-making in key public sector bodies dealing with resource allocation is a major determinant of their efficiency. One of the most difficult and contentious areas of decision-making is the way that uncertainty is dealt with.
Four Case Studies to Explore the Added Value of Oxford AHSN
9 January 2016
The Oxford Academic Health Science Network (Oxford AHSN) wishes to demonstrate the value of the various projects and programmes that the network has developed and implemented since it was established in 2013.
How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?
8 January 2016
This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting, Tokyo. The panel session was entitled “How…